Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-15

Clinical Trial Update: Collaborative Risk-stratified Investigation in Teen Inpatients With Critical Illness: Anticoagulation With LMWH in Kids for ThromboProphylaxis (CRITICAL-Kids-TP) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating low-molecular-weight heparin for preventing venous thromboembolism in hospitalized, critically ill children; status is not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Low molecular weight heparin (LMWH) (low molecular weight heparin)

Snippet

Sponsor: Johns Hopkins All Children's Hospital | Conditions: Venous Thromboembolism (VTE) | Phase 3 | Status: NOT_YET_RECRUITING